<DOC>
	<DOCNO>NCT00870402</DOCNO>
	<brief_summary>The purpose study determine whether spironolactone effective reduction albuminuria diastolic disfunction subject diabetic nephropathy .</brief_summary>
	<brief_title>Aldosterone Diabetic Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Diabetic subject maximum ten year diagnostic Diabetic nephropathy albuminuria Normal renal function Diastolic disfunction Taking IECA ARA drug family previously Diabetics subject macroangiopathy Acute coronary syndrome three month Hyperkalemia &gt; 5.5 mEq/L Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>aldosterone</keyword>
	<keyword>albuminuria</keyword>
	<keyword>diastolic disfunction</keyword>
	<keyword>hyperkalemia</keyword>
</DOC>